Global cell line development market to reach $7.5bn by 2024

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/marchmeen29)
(Image: Getty/marchmeen29)

Related tags: Cell line development, Cell line, Market, Revenue, Research, Mammalian cell culture, Manufacturing, Asia pacific, Monoclonal antibodies

The global cell line development market grows steadily with a predicted revenue of $7.5bn by 2024, each component of the market to see CAGR between 10-15%.

Related news

Related products

Accelerating Time to IND with Pharma 4.0

Accelerating Time to IND with Pharma 4.0

Wheeler Bio | 22-Sep-2022 | Technical / White Paper

The future of the biopharmaceutical industry hinges on its adoption of 21st-century digital tools and automation.

Discover the world of upstream bioprocessing

Discover the world of upstream bioprocessing

Eppendorf Bioprocess Solutions | 07-Sep-2022 | Technical / White Paper

A must-read for all bioprocess scientists: This bundle of four ebooks created by Eppendorf guides you through the world of upstream bioprocessing.

Related suppliers

Follow us

Products

View more

Webinars